 Seth Septer
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 8 | 2022 | 32 | 2.940 |
Why?
| | Adenomatous Polyposis Coli Protein | 2 | 2018 | 18 | 1.160 |
Why?
| | Genetic Counseling | 2 | 2016 | 67 | 1.070 |
Why?
| | Hepatoblastoma | 3 | 2019 | 25 | 0.690 |
Why?
| | Fibromatosis, Aggressive | 2 | 2016 | 18 | 0.640 |
Why?
| | Dentofacial Deformities | 1 | 2018 | 1 | 0.630 |
Why?
| | Osteosclerosis | 1 | 2018 | 2 | 0.630 |
Why?
| | Osteoma | 1 | 2018 | 2 | 0.630 |
Why?
| | Mandibular Neoplasms | 1 | 2018 | 22 | 0.610 |
Why?
| | Genetic Testing | 3 | 2019 | 382 | 0.610 |
Why?
| | Intestinal Polyposis | 2 | 2019 | 7 | 0.610 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2016 | 202 | 0.600 |
Why?
| | Neoplastic Syndromes, Hereditary | 2 | 2019 | 29 | 0.590 |
Why?
| | Counselors | 1 | 2016 | 11 | 0.560 |
Why?
| | Genes, APC | 2 | 2019 | 13 | 0.560 |
Why?
| | Liver Neoplasms | 2 | 2016 | 521 | 0.490 |
Why?
| | Polyps | 1 | 2013 | 11 | 0.440 |
Why?
| | Esophageal Diseases | 1 | 2013 | 24 | 0.430 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2013 | 18 | 0.430 |
Why?
| | Chromosome Deletion | 1 | 2013 | 95 | 0.420 |
Why?
| | Esophagitis | 1 | 2013 | 65 | 0.420 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 340 | 0.420 |
Why?
| | Mutation | 4 | 2018 | 3364 | 0.400 |
Why?
| | Esophagus | 1 | 2013 | 226 | 0.380 |
Why?
| | Barrett Esophagus | 1 | 2013 | 147 | 0.370 |
Why?
| | Genetic Predisposition to Disease | 2 | 2015 | 2125 | 0.340 |
Why?
| | Phosphoproteins | 1 | 2011 | 304 | 0.340 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1048 | 0.330 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 374 | 0.330 |
Why?
| | Liver | 2 | 2018 | 1690 | 0.320 |
Why?
| | Child | 13 | 2022 | 18488 | 0.230 |
Why?
| | Colectomy | 2 | 2016 | 87 | 0.230 |
Why?
| | Child, Preschool | 6 | 2019 | 9133 | 0.220 |
Why?
| | Radiography, Panoramic | 2 | 2021 | 12 | 0.210 |
Why?
| | Infant | 6 | 2016 | 7979 | 0.180 |
Why?
| | Colonoscopy | 3 | 2019 | 204 | 0.160 |
Why?
| | Colonic Polyps | 1 | 2019 | 67 | 0.160 |
Why?
| | Craniopharyngioma | 1 | 2019 | 65 | 0.160 |
Why?
| | Cromolyn Sodium | 1 | 2018 | 13 | 0.160 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2018 | 6 | 0.160 |
Why?
| | Cell Degranulation | 1 | 2018 | 39 | 0.160 |
Why?
| | Jaw | 1 | 2018 | 15 | 0.160 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
| | Cell Proliferation | 2 | 2017 | 2194 | 0.150 |
Why?
| | Mast Cells | 1 | 2018 | 117 | 0.150 |
Why?
| | beta Catenin | 1 | 2019 | 220 | 0.150 |
Why?
| | Adolescent | 7 | 2019 | 17889 | 0.150 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 55 | 0.140 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2017 | 174 | 0.140 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 5 | 0.140 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 19 | 0.130 |
Why?
| | Chemoprevention | 1 | 2016 | 88 | 0.130 |
Why?
| | Prevalence | 2 | 2021 | 2264 | 0.130 |
Why?
| | Capsule Endoscopy | 1 | 2015 | 16 | 0.130 |
Why?
| | Male | 10 | 2019 | 55949 | 0.130 |
Why?
| | Humans | 17 | 2022 | 115587 | 0.130 |
Why?
| | Microbiota | 1 | 2022 | 652 | 0.130 |
Why?
| | Genetic Diseases, Inborn | 1 | 2014 | 37 | 0.120 |
Why?
| | Lymphoproliferative Disorders | 1 | 2014 | 46 | 0.120 |
Why?
| | Female | 10 | 2019 | 59913 | 0.110 |
Why?
| | Colorectal Neoplasms | 2 | 2019 | 617 | 0.110 |
Why?
| | Pediatrics | 3 | 2019 | 986 | 0.110 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2013 | 10 | 0.110 |
Why?
| | Failure to Thrive | 1 | 2013 | 32 | 0.110 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 262 | 0.110 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 174 | 0.110 |
Why?
| | Self Report | 1 | 2016 | 698 | 0.110 |
Why?
| | Stomach | 1 | 2013 | 101 | 0.110 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 68 | 0.100 |
Why?
| | Vomiting | 1 | 2013 | 125 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2016 | 9159 | 0.100 |
Why?
| | Gastritis | 1 | 2013 | 84 | 0.100 |
Why?
| | Phenotype | 3 | 2019 | 2829 | 0.100 |
Why?
| | Mass Screening | 1 | 2019 | 1024 | 0.100 |
Why?
| | Abdominal Pain | 1 | 2013 | 135 | 0.100 |
Why?
| | Ion Transport | 1 | 2011 | 55 | 0.100 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 142 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2017 | 961 | 0.100 |
Why?
| | Deglutition Disorders | 1 | 2013 | 119 | 0.100 |
Why?
| | Retrospective Studies | 3 | 2019 | 12608 | 0.100 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 395 | 0.100 |
Why?
| | Kidney | 1 | 2018 | 1207 | 0.100 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 553 | 0.090 |
Why?
| | Tretinoin | 1 | 2011 | 124 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3022 | 0.090 |
Why?
| | Organ Size | 1 | 2011 | 434 | 0.090 |
Why?
| | Collagen | 1 | 2013 | 415 | 0.090 |
Why?
| | Bile Acids and Salts | 1 | 2011 | 172 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 274 | 0.090 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2011 | 224 | 0.090 |
Why?
| | Optic Neuritis | 1 | 2008 | 37 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 4773 | 0.070 |
Why?
| | Bronchiolitis | 1 | 2008 | 83 | 0.070 |
Why?
| | Pneumonia, Bacterial | 1 | 2008 | 108 | 0.070 |
Why?
| | Feeding and Eating Disorders | 1 | 2008 | 115 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1536 | 0.060 |
Why?
| | Biopsy | 2 | 2022 | 1056 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2011 | 1700 | 0.060 |
Why?
| | Adult | 4 | 2021 | 30718 | 0.060 |
Why?
| | Apoptosis | 1 | 2011 | 2377 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2262 | 0.050 |
Why?
| | Clinical Competence | 1 | 2008 | 912 | 0.050 |
Why?
| | Young Adult | 2 | 2013 | 10470 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 431 | 0.040 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2019 | 59 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 102 | 0.040 |
Why?
| | Animals | 3 | 2018 | 32102 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 131 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 217 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2018 | 3580 | 0.040 |
Why?
| | Connective Tissue Growth Factor | 1 | 2017 | 21 | 0.040 |
Why?
| | Age Factors | 2 | 2015 | 2907 | 0.040 |
Why?
| | Adenoma | 1 | 2019 | 187 | 0.040 |
Why?
| | Gastroenterology | 1 | 2019 | 158 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 532 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2416 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 438 | 0.030 |
Why?
| | Mice | 1 | 2011 | 15052 | 0.030 |
Why?
| | Electronic Mail | 1 | 2015 | 54 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 684 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 44 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 64 | 0.030 |
Why?
| | Canada | 1 | 2015 | 335 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 863 | 0.030 |
Why?
| | Needs Assessment | 1 | 2015 | 318 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 538 | 0.030 |
Why?
| | Dyspepsia | 1 | 2013 | 9 | 0.030 |
Why?
| | Gastric Mucosa | 1 | 2013 | 46 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2418 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 241 | 0.030 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 54 | 0.030 |
Why?
| | Gene Expression | 1 | 2017 | 1435 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 342 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 49 | 0.020 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2011 | 49 | 0.020 |
Why?
| | Cholangiocarcinoma | 1 | 2011 | 38 | 0.020 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 56 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4435 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2604 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 175 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1571 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 962 | 0.020 |
Why?
| | Cell Communication | 1 | 2011 | 282 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3914 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 852 | 0.020 |
Why?
| | Moraxellaceae Infections | 1 | 2008 | 3 | 0.020 |
Why?
| | Cell Survival | 1 | 2011 | 1024 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1805 | 0.020 |
Why?
| | Sampling Studies | 1 | 2008 | 95 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 594 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1598 | 0.020 |
Why?
| | Internship and Residency | 1 | 2015 | 951 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 2751 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 509 | 0.010 |
Why?
| | Transcription Factors | 1 | 2011 | 1528 | 0.010 |
Why?
| | United States | 1 | 2015 | 12295 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4541 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1484 | 0.010 |
Why?
|
|
Septer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|